Statistics for Atara Biotherapeutics (id:8150 ATRA)

Valuation metrics

Market cap

70.61M

Enterprise value

87.50M

Trailing P/E (ttm)

-0.19

Forward P/E

-1.40

PEG ratio

-1.40

Price/Sales (ttm)

1.13

Price/Book (mrq)

-1.01

Enterprise Value/Revenue

1.40

Enterprise Value/EBITDA

-0.54

Overview

Shares outstanding

5.76M

Float

4.07M

Shares short

636.28K

% Held by insiders

0.22%

% Held by institutions

0.51%

Average volume (10 days)

133.80K

Average volume (90 days)

Price summary

52-Week low

6.50

52-Week high

39.50

52-Week change

-41.11%

Beta

0.50

50-Day moving average

9.30

200-Day moving average

12.40

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

June 20th, 2024

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-290.20%

Operating margin

-62.41%

Operational effectiveness

Return on assets

-57.48%

Return on equity

278.27%

Income statement

Revenue (ttm)

12.26

Revenue per share (ttm)

12.26

Quarterly revenue growth (yoy)

Gross profit (ttm)

-313,000.00

EBITDA

-162,124,992.00

Net income to common (ttm)

-181,048,000.00

Diluted EPS (ttm)

-25.32

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

35.29M

Total cash per share (mrq)

7.18

Total debt (mrq)

52.70M

Total Debt/Equity (mrq)

-0.58

Current ratio (mrq)

42.10%

Book value per share (mrq)

-23.30

Cash flow

Cash flow statement

-142,008,992.00

Levered free cash flow (LFCF)

-2,966,750.00